Global Biobanking Market Expanding at 7.5% CAGR During 2016-2024

New York, USA, 2018-Dec-01 — /EPR Network/ — According to Goldstein Research, the Biobanking Market is anticipated to reach a market size of USD 2.83 billion by 2024, growing at 7.5% CAGR over the forecast period 2016-2024. Biobanks are an example of innovation towards excellence. They store the genetic material & information that are very much useful in research projects. Based on sample type segmentation, blood products segment accounted for the largest market share in 2016 due to rising demand for blood products & high incidence of blood disorders.

Browse Full Report:

https://www.goldsteinresearch.com/report/global-biobanking-market-size-2016-2024

Further, the growth and expansion of vertical sectors in healthcare industry tends to have huge positive impact in the growth of global biobanking market, such as Anticoagulation Therapy Market, warm blood perfusion system market, organ care system market and Sample Collection Devices Market. In terms of growth, the Warm Blood Perfusion System Market is growing at a CAGR of 8.01% during the forecast period. Whereas, Organ Care System Market is anticipated to reach USD 0.23 billion by 2025 to provide better time management, improved organ quality and more transplantable organs.

Market Segmentation

Based on our in-depth analysis of Global Biobanking Market, itcan be segmented as follows:

By Type

• Equipment
• Consumables
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids

By Application

• Regenerative Medicine
• Life Science
• Clinical Research

By Region

• North America Biobanking Market Analysis, 2016-2024
• Europe Biobanking Market Analysis, 2016-2024
• Middle East And Africa Biobanking Market Analysis, 2016-2024
• Latin America Biobanking Market Analysis, 2016-2024
• Asia Pacific Biobanking Market Analysis, 2016-2024

 “Global Biobanking Market Outlook 2024” includes a comprehensive overview of the global biobanking market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type, sample type, application, and geography.

Download Exclusive Sample Report:

https://www.goldsteinresearch.com/request-sample/global-biobanking-market-size-2016-2024

Key players mentioned in the report are Thermo Fisher Scientific Inc., Tecan Group Ltd. , Qiagen N.V., Hamilton Company, Brooks Automation, TTP Labtech Ltd, VWR Corporation, Promega Corporation, Worthington Industries,  Chart Industries), Becton, Dickinson and Company, Merck KGaA, Micronic, LVL Technologies GmbH & Co. KG, Panasonic Healthcare Holdings Co. Ltd, Greiner Bio-One, Bioko GmbH, Biobank AS, Biorep Technologies Inc., Cell & Co Bioservices, RUCDR infinite biologics, Modul-Bio, CSols Ltd, Ziath, LabVantage Solutions Inc., etc.

Key Highlights inGlobal Biobanking Market Report:

• The global biobanking market report highlights the competitive outlook of major global players, their business strategies, financial analysis, product portfolio, revenue distribution, R&D activities and investments. The competitive analysis also analyses the mergers, acquisitions and partnership scenario in the industry.

• The comprehensive analysis of biobanking market report is drafted as per the clients to help them in assessing their business strategies in a competitive environment.

• Global biobanking market report encompasses the analysis of new opportunities emerging in the market, major factors driving the growth of the market, and the factors posing threats & challenges to the market.

• The biobanking market outlook also comprises the market analysis based on market dynamics, risk factors, USP analysis, SWOT analysis, BPS Analysis & market attractiveness.

• Further, the biobanking market report includes the expert analysis and remarks showcasing the complete overview of the market based on intensive analysis of political, economic, social, technological, environmental & legal factors of each region covered in the market.